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AbstrACt
Objective To characterise how online media coverage of 
journal articles on cancer funded by the US government 
varies by cancer type and stage of the cancer control 
continuum and to compare the disease prevalence rates 
with the amount of funded research published for each 
cancer type and with the amount of media attention each 
receives.
Design A cross-sectional study.
setting The United States.
Participants The subject of analysis was 11 436 journal 
articles on cancer funded by the US government published 
in 2016. These articles were identified via PubMed and 
characterised as receiving online media attention based on 
data provided by Altmetric.
results 16.8% (n=1925) of articles published on US 
government-funded research were covered in the media. 
Published journal articles addressed all common cancers. 
Frequency of journal articles differed substantially across 
the common cancers, with breast cancer (n=1284), lung 
cancer (n=630) and prostate cancer (n=586) being the 
subject of the most journal articles. Roughly one-fifth to 
one-fourth of journal articles within each cancer category 
received online media attention. Media mentions were 
disproportionate to actual burden of each cancer type 
(ie, incidence and mortality), with breast cancer articles 
receiving the most media mentions. Scientific articles also 
covered the stages of the cancer continuum to varying 
degrees. Across the 13 most common cancer types, 4.4% 
(n=206) of articles focused on prevention and control, 
11.7% (n=550) on diagnosis and 10.7% (n=502) on 
therapy.
Conclusions Findings revealed a mismatch between 
prevalent cancers and cancers highlighted in online media. 
Further, journal articles on cancer control and prevention 
received less media attention than other cancer continuum 
stages. Media mentions were not proportional to actual 
public cancer burden nor volume of scientific publications 
in each cancer category. Results highlight a need for 
continued research on the role of media, especially online 
media, in research dissemination.
IntrODuCtIOn 
The US federal government is the largest 
funder of cancer research in the world.1 
Thus, as a public good, it is imperative that 
the results from federally funded cancer 
research be optimally disseminated to all 
stakeholders, including clinicians, funders, 
policy-makers and the public. The mass 
media play a key role in this dissemination.2–5 
To this end, scientific journals have adopted 
media outreach strategies, such as the Journal 
of the National Cancer Institute’s ‘Memo to the 
Media’, to facilitate research dissemination.
Media coverage is critical to health commu-
nication across the cancer continuum with 
particular influence on cancer perceptions 
and the preventive and screening behaviours 
among the public.6–8 Yet little is known about 
the alignment between the characteristics of 
federally funded research articles and how 
they are covered in the media. This is espe-
cially true in light of the expanding nature 
of the digital media landscape. Such a lack 
of knowledge impedes the identification and 
mitigation of any potential discrepancies 
between the state of the research and what is 
depicted in the media. Additionally, it disad-
vantages the public because people may not 
be exposed to relevant research for making 
personal health decisions.
strengths and limitations of this study
 ► Our findings provide funder groups a replicable 
method for future tracking of the characteristics of 
outputs from their research portfolio that appear in 
the online news media.
 ► We include a broad mix of online media organisa-
tions, such as traditional news media, broadcast or-
ganisations, trade publications, health and science 
news aggregators, and press release wire services 
and public relations platforms.
 ► The broad inclusion of online media organisations 
is critical as traditional news media are no longer 
the only sources, nor the primary sources, of health 
information for the public.
 ► The presented method includes only journal articles 
indexed in MEDLINE, which omits articles published 
in journals not indexed in that resource.
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In the USA, cancer is the most covered disease in the 
news9 and the public relies on this coverage as a key source 
of cancer information.10 11 In turn, news reports of cancer 
research help shape public cancer beliefs,7 8 12 subsequent 
prevention and detection behaviours13 14 and treatment 
preferences.4 Thus, a mismatch between media attention 
and available evidence can be problematic. For example, 
past content analyses found breast, blood and pancreatic 
cancers to be over-represented in the news relative to their 
actual prevalence, while male reproductive, lymphatic 
and thyroid cancers were under-represented relative to 
prevalence.5 15–17 Prevention and detection research also 
tended to receive less news coverage than other stages 
of the cancer continuum, such as cancer treatment.5 8 17 
While these prior media content analyses provide valu-
able information, they are based on older data, do not 
focus specifically on coverage of research and narrowly 
focus their analysis on selected mainstream news outlets. 
For example, researchers in 2010 analysed 13 mainstream 
print newspapers and magazines from 2005 to 2007, 
deciding to exclude online and niche news organisa-
tions.18 Thus, existing research fails to account for today’s 
broad spectrum of online media that encompasses tradi-
tional online news sources as well as trade publications, 
health and science news aggregators, and press release 
wire services.
The current study aims to characterise and analyse 
cancer research articles funded by the US government, 
including those featured in a collection of more than 
2000 online media sources. This analysis provides funders, 
scientists and policy-makers with an understanding of the 
dissemination of federally funded research via online 
media—information useful in future dissemination and 
funding initiatives. Additionally, this study provides a 
replicable method for tracking and analysing the outputs 
of funded research across a range of online media, which 
is critical as traditional news media are no longer the 
only sources, nor the primary sources, of health informa-
tion for the public.19
MethODs
We conducted a cross-sectional study to examine journal 
articles on cancer funded by the US government and 
published in 2016 with the objectives of: (1) identi-
fying, examining and characterising how the number 
of mentions of research in online news media varies by 
cancer type and stage of the cancer control continuum 
and (2) comparing the disease prevalence rates with the 
amount of funded research published for each cancer 
type and with the amount of media attention each 
receives.
To facilitate transparency and replication of our 
methods, we have made our computer code and the proj-
ect’s complete data set publicly accessible at https:// doi. 
org/ 10. 5281/ zenodo.1306985.
Patient and public involvement
Patients and the public were not involved in this study.
search strategy
To locate articles, we searched PubMed on 1 March 
2018, using the Entrez Programming Utilities20 with a 
query describing all documents published in journals 
(including editorials, letters to the editors, etc) about 
cancer published in 2016 with any identified source of 
funding (see table 1 for search details). We then extracted 
the record for each document including bibliographic 
data, funding information and Medical Subject Heading 
(MeSH) terms.
Inclusion and exclusion criteria
To meet our objective of identifying and characterising 
cancer articles that received media attention, we included 
journal articles on cancer funded by the US government 
that were published in 2016. We also specifically focused 
on articles that were described by National Library of 
Medicine indexers as being about the cancer types most 
frequently diagnosed in the USA, excluding non-mela-
noma skin cancers. These include cancers of the lung, 
colon and rectum, pancreas, breast, liver, prostate, 
leukaemia, non-Hodgkin’s lymphoma, bladder, kidney, 
endometrium, melanoma and thyroid (in order of esti-
mated deaths).21
Articles indexed with MeSH terms for a common 
cancer or a respective child term were counted as being 
about that particular cancer (eg, an article indexed with 
‘Leukemia, Plasma Cell’ was counted toward the parent 
term ‘Leukemia’). When terms for more than one cancer 
type were included in an article, we counted the article 
as an occurrence of each cancer. We categorised articles 
not described by at least one of these prevalent cancer 
types as ‘other’. Due to a lack of standardised terminology 
for stages of the cancer continuum, we partitioned the 
Table 1 PubMed search strategy for US government-funded research on cancer
Keywords neoplasm[mesh] OR "neoplasm metastasis"[mesh] OR cancer*[tiab] OR malign*[tiab] OR neoplas*[tiab] OR 
oncolo*[tiab] OR metasta*[tiab] OR tumor*[tiab] OR tumour*[tiab]
Funding "research support, american recovery and reinvestment act"[Publication Type] OR "research support, n i 
h, extramural"[Publication Type] OR "research support, n i h, intramural"[Publication Type] OR "research 
support, non u s gov't"[Publication Type] OR "research support, u s gov't, non p h s"[Publication Type] OR 
"research support, u s gov't, p h s"[Publication Type] OR "research support, u s government"[Publication 
Type]
Publication date "2016/01/01"[Date - Publication]: "2016/12/31"[Date - Publication]
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continuum into stages: prevention and control, diagnosis 
and treatment. We used corresponding MeSH qualifiers 
‘prevention and control’, ‘diagnosis’ and ‘therapy’.
After identifying relevant documents, we determined if 
they had received media attention by searching each docu-
ment’s PubMed identifier in the database from Altmetric 
LLC on 2 March 2018. For the purpose of this paper, we 
used Altmetric’s definition of ‘news media’ sources, such 
that if either a link to a journal article or a phrase refer-
encing a journal article was identified in any of the more 
than 2000 global media sources tracked by Altmetric, 
then it was considered a media mention. Altmetric tracks 
traditional news outlets such as the BBC News, Los Angeles 
Times, New York Times and Washington Post, as well as newer, 
online-only sources such as The Daily Beast, Huffington Post 
and Vox. Additionally, the company tracks non-profit and 
governmental media organisations such as Kaiser Health 
News, Mayo Clinic and Voice of America, as well as niche 
news aggregators and portals such as BioMedReports, 
EurekAlert and Health Medicinet. Altmetric also tracks press 
release news wires such as BusinessWire and PR Newswire. 
In this study, we consider all these sources in our defini-
tion of ‘media’, and count every time Altmetric LLC finds 
a ‘mention’ of an article in one of these sources. (For a 
listing of media sources, see Altmetric.22) Of note, while 
Altmetric also tracks the attention research receives on 
social media, such as mentions in Facebook and Twitter 
posts, these forms of attention are outside the scope of 
this study.
statistical analysis
Descriptive statistics were calculated to provide a base-
line understanding of the frequency and proportions of 
journal article characteristics, as well as identify potential 
differences in the types of cancers and related stages of 
the cancer continuum covered. Subsequently, we exam-
ined the frequency and proportions of media mentions 
received by the articles. Analyses were conducted using 
SPSS V.21 and Microsoft Excel 365 ProPlus.
results
We identified 2 00 264 articles in PubMed on cancer 
published in 2016. Of these, 11 436 (5.7%) reported a 
US government funding source (all subsequent analysis 
refers to this subset of n=11 436, unless otherwise spec-
ified). The majority of US government-funded articles 
received funding from the National Institutes of Health 
(NIH; table 2) and many received a combination of 
funding from US government and non-US government 
sources, such that there were 19 944 total funding sources 
across all articles.
Articles with multiple funding sources are counted 
once for each source.
All 13 common forms of cancer were the subject of at 
least one journal article (table 3). Overall, 41.0% (n=4687) 
of journal articles about cancer addressed at least one 
of these common types of cancer. Most journal articles 
addressed only one of the top 13 cancers (n=4448), 195 
journal articles addressed 2 top cancers and 44 journal 
articles addressed 3–5 top cancers. Frequency of scientific 
articles differed substantially across the common cancers, 
with breast cancer (n=1284), lung cancer (n=630) and 
prostate cancer (n=586) being the subject of the most 
publications (table 3; figure 1).
US government-funded articles were featured in 
1483 unique scientific journals. Articles appeared most 
frequently in the journals Cancer Research (n=292, 2.6%), 
PLOS One (n=190, 1.7%) and Proceedings of the National 
Academy of Sciences (PNAS) (n=179, 1.6%). Overall, the 10 
journals with the most US government-funded cancer 
research articles accounted for 14.2% of the total sample 
of articles (table 4).
Scientific articles also covered the stages of the cancer 
continuum to varying degrees (table 5; figure 2). Across 
the 13 most common cancer types, 4.4% (n=206) of arti-
cles focused on prevention and control, 11.7% (n=550) 
on diagnosis and 10.7% (n=502) on therapy.
Mentions in online media
A total of 1925 (16.8%) of cancer research articles were 
mentioned in online media at least once. The majority 
(n=9511, 83.2%) of journal articles did not receive 
a media mention (median=0, mean=1.84, SD=11.98, 
range=0–462). Of the 1925 articles that did receive at 
least one media mention, 735 received just one mention 
(6.4%), 198 received two mentions (1.7%) and 992 
(8.8%) received three or more mentions. Four articles 
received over 300 mentions (table 6).23–32
The frequency of media mentions differed across cancer 
types (table 7; figure 3). The proportion of journal arti-
cles, by cancer type, receiving at least one media mention 
ranged from 7.0% of thyroid cancer articles to 24.8% of 
melanoma articles. Thus, while breast cancer had the 
largest total number of articles with one or more media 
mentions (251), melanoma articles received the largest 
relative proportion of coverage (24.8%). In other words, 
while breast cancer research may have the widest reach 
in terms of absolute number of online media mentions, 
Table 2 Number of articles reporting each source of 
funding support
Funding source*
Number of 
articles
NIH Extramural 10 377
NIH Intramural 594
American Recovery & Reinvestment Act 10
US government Non-Public Health Services 1922
US government Public Health Services 295
Non-US government 6746
*Funding sources defined: https://www.nlm.nih.gov/pubs/techbull/
mj05/mj05_support_heading.html
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a larger proportion of journal articles on melanoma are 
being mentioned online.
Media coverage also varied across cancer continuum 
stage for the top 13 cancers. While prevention and 
control articles received more relative coverage (32.0%), 
compared with diagnosis (20.0%) or treatment (20.3%), 
this stage had fewer absolute mentions (66 mentions) 
compared with other stages (110 and 102 mentions, 
respectively), translating into lower absolute dissemina-
tion for the earliest stage of the continuum.
DIsCussIOn
Media coverage is a key access point to cancer infor-
mation for the public.10 11 In this study, approximately 
one out of every six articles reporting a US govern-
ment funding source received media attention. For the 
public to receive useful information to guide health, it 
is imperative that the information disseminated to the 
public be accurately interpreted and aligned with avail-
able evidence.33 Our findings provide stakeholders with 
a valuable formative landscape of the current dissemina-
tion of federally funded cancer research captured across 
a spectrum of online media attention, including tradi-
tional news sources as well as trade publications, health 
and science news aggregators and press release wire 
services. Looking to the future, our approach provides 
funder groups, such as the National Cancer Institute 
(NCI) and NIH, with a replicable method for tracking 
Table 3 Common cancer types covered by journal articles resulting from US government funds in relation to the number of 
estimated new cases in 2017 and estimated deaths21
Cancer type
No. of scientific articles 
published in 2016 (n=4984*)
No. of estimated new 
cases (rank)
No. of estimated deaths 
(rank)
Breast 1284 2 55 190† (1) 41 070‡ (4)
Lung 630 2 22 500 (2) 1 55 870 (1)
Prostate 586 1 61 360 (3) 26 730 (6)
Colon and rectal 535 1 35 430 (4) 50 260 (2)
Leukaemia 544 62 130 (9) 24 500 (7)
Pancreatic 309 53 670 (12) 43 090 (3)
Liver 302 40 710 (13) 28 920 (5)
Melanoma 302 87 110 (5) 9730 (12)
Non-Hodgkin’s lymphoma 170 72 240 (7) 20 140 (8)
Kidney 106 63 990 (8) 14 400 (10)
Endometrial 77 61 380 (10) 10 920 (11)
Thyroid 71 56 870 (11) 2010 (13)
Urinary/bladder 68 79 030 (6) 16 870 (9)
*Articles may be counted multiple times if they include two or more cancers.
†Breast cancer total new cases 2 55 190 (25 2710 females; 2470 males).
‡Breast cancer total estimated deaths 41 070 (40 610 females; 460 males).
Figure 1 Common cancer types covered by journal articles resulting from US government funds in relation to the number of 
estimated new cases in 2017 and estimated deaths.21 *NH, non-Hodgkin.
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outputs from their research portfolio as they appear in 
online media.
While journal articles spanned all common cancer 
types, they were not represented in proportions mirroring 
estimates of cancer burden. Similar to earlier findings,5 
breast cancer was the most-published-on cancer type, 
with more than double the frequency of the second-
most focused-on cancer, despite breast cancer causing 
fewer deaths than lung, colon and rectal, and pancre-
atic cancers. Prior research found a similar mismatch 
between the cancers prominent in the scientific literature 
and those with the highest actual burden (ie, prevalence, 
incidence or mortality).5 15–17 This misalignment is note-
worthy and the public, physicians, policy-makers and the 
media should understand that the research volume does 
not necessarily indicate the severity or population-level 
burden of the disease. It should also be noted that a 
complex set of factors, including investigator-initiated 
research proposals and available funding, influences 
scientific research.
Published articles disproportionately represented the 
stages of the cancer continuum, with prevention and 
control research accounting for a smaller proportion 
than diagnosis or treatment research. This echoes prior 
Table 4 Top 10 journals featuring the most US government-funded cancer research articles, with and without media coverage
Journal
Total funded articles in 
2016 (% of total articles)
Funded articles with 
media coverage (% 
of articles in journal)
Funded articles without 
media coverage (% of 
articles in journal)
1 Cancer Research 292 (2.6) 88 (30.1) 204 (69.9)
2 PLOS One 190 (1.7) 20 (10.5) 170 (89.5)
3 Proceedings of the National Academy of the 
Sciences (PNAS)
179 (1.6) 84 (46.9) 95 (53.1)
4 Oncotarget 151 (1.3) 2 (1.3) 149 (98.7)
5 Blood 149 (1.3) 40 (26.8) 109 (73.2)
6 The Journal of Biological Chemistry 147 (1.3) 10 (6.8) 137 (93.2)
7 Scientific Reports 145 (1.3) 25 (17.2) 120 (82.8)
8 International Journal of Radiation Oncology, 
Biology, Physics
125 (1.1) 27 (21.6) 98 (78.4)
9 Breast Cancer Research and Treatment 118 (1.0) 10 (8.5) 108 (91.5)
10 International Journal of Cancer 112 (1.0) 13 (11.6) 99 (88.4)
Table 5 Scientific journal articles that identify a stage of cancer continuum
Cancer type
Prevention 
and control 
articles (%)
Prevention and 
control articles with 
1+media mentions (%)
Diagnosis 
articles
Diagnosis articles 
with 1+media  
mentions (%)
Therapy 
articles
Therapy articles 
with 1+media  
mentions (%)
Breast 55 (4.3) 21 (38.2) 147 (11.4) 30 (20.4) 111 (8.6) 24 (21.6)
Lung 25 (4.0) 4 (16.0) 68 (10.8) 10 (14.7) 70 (11.1) 12 (17.1)
Colon and rectal 53 (9.9) 19 (35.8) 123 (23.0) 27 (22.0) 45 (8.4) 7 (15.6)
Leukaemia 18 (3.3) 3 (16.7%) 52 (9.6) 11 (21.2) 87 (16.0) 16 (18.4)
Liver 15 (5.0) 2 (13.3) 28 (9.3) 1 (3.6) 35 (11.6) 6 (17.1)
Prostate 25 (4.3) 8 (32.0) 68 (11.6) 18 (26.5) 53 (9.0) 9 (17.0)
Melanoma 11 (3.6) 5 (45.5) 24 (7.9) 6 (25.0) 44 (14.6) 11 (25.0)
Pancreatic 11 (3.6) 2 (18.2) 28 (9.1) 3 (10.7) 36 (11.7) 4 (11.1)
Non-Hodgkin’s lymphoma 2 (1.2) 0 (0.0) 21 (12.4) 3 (14.3) 31 (18.2) 8 (25.8)
Kidney 1 (0.9) 0 (0.0) 12 (11.3) 0 (0.0) 9 (8.5) 2 (22.2)
Thyroid 1 (1.4) 0 (0.0) 7 (9.9) 0 (0.0) 6 (8.5) 3 (50.0)
Urinary/bladder 3 (4.4) 1 (33.3) 12 (17.6) 1 (8.3) 13 (19.1) 0 (0.0)
Endometrial 3 (3.9) 1 (33.3) 5 (6.5) 0 (0.0) 8 (10.4) (0.0)
Total 13 common cancer 
types (4687)*
206 (4.4) 550 (11.7) 502 (10.7)
Total (11 436)* 519 (4.5) 1000 (8.7) 1198 (10.5)
*Articles may address more than one stage in the cancer continuum. Therefore, these two totals do not reflect unique articles.
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research findings highlighting an under-representation 
of prevention-focused research.5 8 17 Notably, there were 
a number of cancers (eg, lung, melanoma) with a surpris-
ingly low amount of prevention/control research repre-
sented in this sample.
Online media mentions were somewhat compa-
rable across the 13 common cancers: around one-fifth 
to one-quarter of journal articles on each cancer type 
received media attention (with the exception of thyroid 
cancer, which was substantially lower). However, similar 
to publication volume, the volume of media mentions per 
cancer type was disproportionate to actual incidence of 
each cancer type and varied across the cancer continuum. 
Breast cancer was the most mentioned cancer type in 
online media, mirroring the higher volume of published 
scientific articles about breast cancer. This aligns with 
prior research that found certain cancers, including 
breast cancer, were over-represented in news coverage 
relative to incidence and mortality rates.5 Although fewer 
scientific articles on melanoma were published during 
this same period, melanoma research had the highest 
amount of relative media attention or per cent of arti-
cles receiving media mentions (24.8%). We also found 
limited media attention to cancer prevention and detec-
tion research across the top 13 cancer types, consistent 
with past studies.5 15
Due to the nature of our methods, we may have inad-
vertently excluded articles. For example, we included 
Figure 2 Articles indexed as addressing the prevention and control, diagnosis or therapy stages of the cancer continuum. 
Articles may address more than one stage in the cancer continuum. Therefore, these two totals do not reflect unique articles. 
*NH, non-Hodgkin.  o
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only articles indexed in MEDLINE, which omits articles 
published in journals not indexed there. Additionally, 
authors or publishers may have failed to report funding 
sources; however, the NIH reports 89% compliance with 
the requirement to deposit manuscripts.34 In relation to 
content, we recognise that the US government also funds 
basic research that while in the future may greatly influ-
ence clinical cancer research, at this time would not be 
specifically indexed as cancer-related and therefore not 
retrieved. It is also possible that some articles related to 
cancer prevention/control (eg, topics such as tobacco 
cessation interventions) did not include relevant MeSH 
(eg, neoplasm) constituting our search criteria. Addition-
ally, articles containing MeSH for more than one cancer 
type were included in counts across multiple categories, 
which may affect estimation. Media mention data were 
Table 6 Top 10 articles by media mentions
Rank Journal Article title
No of media 
mentions
1 Lancet Does physical activity attenuate, or even eliminate, the detrimental 
association of sitting time with mortality? A harmonised meta-analysis of 
data from more than 1 million men and women23
462
2 Oncogene* Targeting MET and AXL overcomes resistance to sunitinib therapy in renal 
cell carcinoma24
355
3 JAMA Dermatology The risk of cancer in patients with psoriasis: A population-based cohort 
study in the Health Improvement Network25
346
4 JAMA Screening for Colorectal Cancer: US Preventive Services Task Force 
Recommendation Statement26
317
5 Science Mutational signatures associated with tobacco smoking in human cancer27 244
6 Nature Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan28 221
7 Journal of 
Psychopharmacology
Rapid and sustained symptom reduction following psilocybin treatment 
for anxiety and depression in patients with life-threatening cancer: a 
randomized controlled trial29
200
8 JAMA CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 
201630
183
9 Science The phenotypic legacy of admixture between modern humans and 
Neanderthals31
178
10 JAMA Psychiatry Association of religious service attendance with mortality among women32 176
*Oncogene is a Nature journal.
Table 7 Number of scientific articles about common cancer types in relation to media mentions
Cancer type*
Total scientific 
articles
Articles (%) with at least 
one media mention
Total media 
mentions across 
articles
Average number of media 
mentions per article of 
those with mentions (range)
Breast 1284 251 (19.5) 2152 8.57 (1–118)
Lung 630 115 (18.3) 1043 9.07 (1–100)
Colon 535 116 (21.7) 1585 13.66 (1–317)
Leukaemia 544 114 (21.0) 830 7.28 (1–57)
Liver 302 51 (16.9) 518 10.16 (1–117)
Prostate 586 116 (19.8) 984 8.48 (1–160)
Melanoma 302 75 (24.8) 938 12.51 (1–139)
Pancreatic 309 61 (19.7) 491 8.05 (1–83)
Non-Hodgkin’s lymphoma 170 33 (19.4) 181 5.48 (1–61)
Kidney 106 22 (20.8) 494 22.45 (1–355)
Thyroid 71 5 (7.0) 51 10.20 (1–31)
Urinary/bladder 68 11 (16.2) 27 2.45 (1–9)
Endometrial 77 12 (16.8) 109 9.08 (1–45)
*Articles can be included in more than one cancer type.
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collected by Altmetric, which searches online media for 
mentions of articles based on unique article IDs (eg, 
PubMed IDs), links to publisher websites and a series 
of proprietary techniques. Altmetric’s approach, to our 
knowledge, offers the most comprehensive tracking of 
research in online media, but it remains imperfect, with 
some errors readily identifiable and an unknown number 
of missed mentions. Furthermore, while Altmetric 
searches over 2000 sources, other potentially important 
sources may not be included.
More broadly, while online media outlets are important 
channels for disseminating health information, we recog-
nise there are other impactful channels, such as social 
media campaigns, that warrant study.3 Further, while we 
focused on the characteristics of scientific journal articles 
receiving media mentions, it is also important to consider 
how such research is covered and portrayed in the news 
media—notably online, where readership shows signs of 
growth—suggesting a future research opportunity.
Our findings provide a unique understanding of the 
dissemination of federally funded cancer research in 
online media via an extensive collection of media sources. 
This benchmark can be used to evaluate future dissemi-
nation and funding initiatives that take into consider-
ation the new information landscape that reaches beyond 
traditional news media. Second, these results can inform 
scientists as to the characteristics of cancer research 
mentioned in the media. Third, these findings provide 
funder groups, such as the NCI and NIH, with a repli-
cable method for future tracking of the outputs from 
their research portfolio that appear in the online news 
media.
Media mentions of research can impact the public’s 
healthcare utilisation, physicians’ practices and research 
funding agendas.35 For example, researchers credit a 
rapid decline in use of hormone replacement therapy by 
women and their physicians to the news media coverage 
of a randomised trial linking the therapy to potential 
harms.36 37 Additionally, media coverage can influence 
which research focus (eg, cancer types, cancer stages) is 
likely to receive federal funding, public policy attention or 
scholarly/scientific attention. A 2014 analysis found that 
discrepancies in media coverage and in public estimates 
of cancer were mirrored in federal funding for cancer 
research (eg, over-representation of breast and blood 
cancers and under-representation of bladder cancer, rela-
tive to actual incidence).7) This highlights an important 
area for future examination; data and methods from this 
study could facilitate such efforts.
Researchers have found that online media attention 
to scientific articles about cancer treatment correlates 
positively with the presence of media outreach.38 39 
Thus, unsurprisingly the top 10 articles receiving the 
most media attention were published in journals that 
engage in outreach and dissemination activities. For 
example, four of the articles appear in the JAMA 
Network. The JAMA Network promises prospective 
authors a dedicated media team and formal press 
office that provides journalists early access to articles, 
writes press releases, and creates video and audio 
recordings of scientists discussing their findings. 
Similar services are provided by the Lancet, Science and 
Nature publishing groups, which account for all but 
one of the top 10 articles. Although we were unable 
to test the effect of such offices or services, because of 
a lack of a comprehensive list, the presence of papers 
among the most mentioned from publishers who are 
known to use them suggests an important role for 
targeted media outreach in ensuring that a broader 
range of scientific research receives online media 
Figure 3 Articles with at least one news mention by cancer type. *NH, non-Hodgkin. ** Some outliers are not displayed in the 
figure as the y-axis was truncated at Q3 + 1.5 *IQR. 
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coverage. Similarly, we were unable to test the indi-
vidual media outreach practices that scientists, univer-
sities and scholarly societies may be employing, as this 
information is not captured systematically anywhere. 
Despite this limitation, we speculate that a need likely 
exists for more affordable outreach and dissemina-
tion services.
Media are recognised as an important channel for 
knowledge dissemination.3 However, online media 
generally have received little attention as a communi-
cation channel in science dissemination models and 
frameworks. Future research should examine how 
online media could be optimally incorporated into 
dissemination processes and knowledge translation 
strategies. Specifically, it will be useful to understand 
how marketing/communications teams can work 
with researchers to connect media more directly with 
emerging scientific research.
As a strength of this research, we included a broad 
mix of online media organisations, including tradi-
tional news media, broadcast organisations, trade publi-
cations, health and science news aggregators, and press 
release wire services and public relations platforms. This 
broad inclusion is critical as traditional news media are 
no longer the only sources, nor the primary sources, of 
health information for the public.19
Thus, our findings provide a unique understanding of 
dissemination of the results of federally funded cancer 
research in the broader landscape of online media. This 
benchmark can be used to evaluate future dissemination 
and funding initiatives that take into consideration the 
new information landscape that reaches far beyond tradi-
tional news media.
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